首页 › 基金 › DAFNA Capital Management LLC › NGEN
DAFNA Capital Management LLC 对 NGEN 的持仓历史
NERVGEN PHARMA CORP · 医疗保健
DAFNA Capital Management LLC 在 Q3 2026 的 13F 申报中披露持有 NGEN(NERVGEN PHARMA CORP)810,862 股,市值约 US$1.5M,约占其申报组合的 0.33%,在其申报持仓中市值排名第 49 位。 DAFNA Capital Management LLC 最近 2 个申报季度中有 2 个季度披露了 NGEN 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
DAFNA Capital Management LLC 对 NGEN 的持仓演变
DAFNA Capital Management LLC 于 Q2 2026 首次披露 NGEN 持仓:1,050,000 股(约 US$2.2M)。 在 2 次申报中,DAFNA Capital Management LLC 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 810,862 股、市值约 US$1.5M,环比减持 -239,138 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 1.05M | $2.16M | 新进 |
| Q3 2026 | 810.86K | $1.55M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NGEN 与 13F 数据
NGEN(NERVGEN PHARMA CORP)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 NGEN,申报仓位最大的包括:Empery Asset Management, LP (US$6.3M), VALLEY FORGE INVESTMENT CONSULTANTS INC ADV (US$1.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NGEN 的基金
- Empery Asset Management, LP 3.31M 股 · $6.32M · Q3 2026
- VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 834.16K 股 · $1.59M · Q3 2026
更多关于 DAFNA Capital Management LLC
常见问题
How long has DAFNA Capital Management LLC held NGEN?
DAFNA Capital Management LLC has disclosed NGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is DAFNA Capital Management LLC's current position in NGEN?
As of Q3 2026, DAFNA Capital Management LLC holds 810.86K shares of NGEN (NERVGEN PHARMA CORP), valued at $1.55M, representing 0.33% of its reported portfolio and ranking #49.
Has DAFNA Capital Management LLC been buying or selling NGEN?
In the latest 13F filing (Q3 2026), DAFNA Capital Management LLC reduced its position in NGEN.
Which other funds hold NGEN?
Other major institutional holders of NGEN include Empery Asset Management, LP, VALLEY FORGE INVESTMENT CONSULTANTS INC ADV, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.